Clover Health Inv Stock Net Income
| 7QD Stock | 3.01 0.16 5.05% |
CLOVER HEALTH INV fundamentals help investors to digest information that contributes to CLOVER HEALTH's financial success or failures. It also enables traders to predict the movement of CLOVER Stock. The fundamental analysis module provides a way to measure CLOVER HEALTH's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CLOVER HEALTH stock.
CLOVER |
CLOVER HEALTH INV Company Net Income Analysis
CLOVER HEALTH's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, CLOVER HEALTH INV reported net income of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Healthcare Plans (which currently averages 0.0) industry. The net income for all Germany stocks is 100.0% higher than that of the company.
CLOVER Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CLOVER HEALTH's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CLOVER HEALTH could also be used in its relative valuation, which is a method of valuing CLOVER HEALTH by comparing valuation metrics of similar companies.CLOVER HEALTH is currently under evaluation in net income category among its peers.
CLOVER Fundamentals
| Return On Equity | -1.1 | |||
| Return On Asset | -0.22 | |||
| Profit Margin | (0.15) % | |||
| Operating Margin | (0.14) % | |||
| Shares Outstanding | 383.55 M | |||
| Shares Owned By Insiders | 13.15 % | |||
| Shares Owned By Institutions | 32.44 % | |||
| Revenue | 3.04 B | |||
| Gross Profit | (189.81 M) | |||
| EBITDA | (437.49 M) | |||
| Book Value Per Share | 0.82 X | |||
| Earnings Per Share | (1.34) X | |||
| Target Price | 9.0 | |||
| Number Of Employees | 680 | |||
| Beta | 1.93 | |||
| Market Capitalization | 548.87 M |
About CLOVER HEALTH Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CLOVER HEALTH INV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CLOVER HEALTH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CLOVER HEALTH INV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in CLOVER Stock
CLOVER HEALTH financial ratios help investors to determine whether CLOVER Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CLOVER with respect to the benefits of owning CLOVER HEALTH security.